Kiniksa Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsKiniksa Pharmaceuticals

Kiniksa Pharmaceuticals(KNSA)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Arcalyst	Rilonacept	2008-02-27		Inborn genetic diseases , Inflammation , Cryopyrin-associated periodic syndromes

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

,

juvenile arthritis

,

,

systemic scleroderma

,

localized scleroderma

,

diffuse scleroderma

,

,

chronic renal insufficiency

,

kidney diseases

,

,

,

,

,

inborn genetic diseases

,

cryopyrin-associated periodic syndromes

,

healthy volunteers/patients

,

rheumatoid arthritis

,

,

respiratory insufficiency

,

severe acute respiratory syndrome-related coronavirus

,

,

,

respiratory distress syndrome

,

viral pneumonia

,

,

giant cell arteritis

,

polymyalgia rheumatica

,

,

,

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

prostatic neoplasms

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

breast neoplasms

,

non-hodgkin lymphoma

,

b-cell lymphoma

,

hepatocellular carcinoma

,

liver neoplasms

,

,

ovarian neoplasms

,

fallopian tube neoplasms

,

ovarian epithelial carcinoma

breast neoplasms

,

triple negative breast neoplasms

,

,

cytomegalovirus retinitis

,

ovarian neoplasms

,

fallopian tube neoplasms

,

ovarian epithelial carcinoma

,

peritoneal neoplasms

,

atherosclerosis

,

intracranial arteriosclerosis

,

fallopian tube neoplasms

,

healthy volunteers/patients

,

,

,

squamous cell carcinoma

,

hypersensitivity

,

non-small-cell lung carcinoma

,

triple negative breast neoplasms

,

ovarian epithelial carcinoma

,

renal cell carcinoma

,

,

peanut hypersensitivity

,

allergic rhinitis

,

,

basal cell carcinoma

,

squamous cell carcinoma of head and neck

,

merkel cell carcinoma

,

neoplasm metastasis

,

basal cell neoplasms

,

,

,

,

adenocarcinoma of lung

,

milk hypersensitivity

,

multiple myeloma

,

plasma cell neoplasms

,

smoldering multiple myeloma

,

paraproteinemias

,

monoclonal gammopathy of undetermined significance

,

prostatic neoplasms

,

colorectal neoplasms

,

head and neck neoplasms

,

ovarian neoplasms

,

retinal diseases

,

diabetic retinopathy

,

,

,

protein-losing enteropathies

,

intestinal diseases

,

myositis ossificans

,

vitreous hemorrhage

,

type 2 diabetes mellitus

,

hyperlipidemias

,

diabetes mellitus

,

macular degeneration

,

,

,

neurodermatitis

,

ulcerative colitis

,

,

,

,

,

chronic urticaria

,

,

,

systemic scleroderma

,

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

interstitial lung diseases

,

diffuse scleroderma

,

hip osteoarthritis

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

knee osteoarthritis

,

breast neoplasms

,

triple negative breast neoplasms

,

,

cytomegalovirus retinitis

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use